Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Board of Directors of MMC Norilsk Nickel recommended that dividends be paid for 9 months 2023

11/3/23 GMKN

SPB Exchange resumes trading in Russian securities

11/3/23 SPBE

GIT reported for 9 months of 2023 by RAS

11/3/23 GRNT

SPB Exchange will withdraw from the capital of Kazakhstan's ITS

11/3/23 SPBE

YES! discounters' revenue grew 18.9% in the first nine months of 2023

11/3/23 OKEY

SPB Exchange summarized results of trading in October

11/3/23 SPBE

Eurotrans starts collecting exchange applications for participation in the IPO

11/3/23 EUTR

Kurgan Generation Company reported for 9 months of 2023 by RAS

11/3/23 KGKC

SPB Exchange will resume trading on November 6 at the earliest

11/3/23 SPBE

Block reported for 9 months of 2023

11/3/23 SQ